We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to End Free Pass on Pediatric Studies of Orphan Drugs, Gottlieb Says
FDA to End Free Pass on Pediatric Studies of Orphan Drugs, Gottlieb Says
The FDA will move to close a loophole in the program to foster study of treatments for rare pediatric illnesses, agency commissioner Scott Gottlieb said in a blog post.